Members of the PREVAIL team, with their research partners, recently published results from clinical trials of three vaccine regimens against Zaire Ebola virus disease (EVD).
TrialSite News podcast: Patient recruitment challenges for COVID-19 clinical trials
FHI Clinical collaborating with Tactical Therapeutics, Inc., to refine the protocol for the development of carboxyamidotriazole orotate (CTO) to treat respiratory diseases
December 21, 2022
FHI Clinical is contributing to the protocol design for a Phase 2 clinical trial to evaluate carboxyamidotriazole orotate (CTO), an asset from Tactical Therapeutics.
October 12, 2022
FHI Clinical Inc. is showcasing sub-Saharan Africa as a clinical trial destination through its 8-week FHI Clinical Africa campaign, culminating in a celebration at World Vaccine Congress Europe of the region’s rich cultural heritage and growing target as a hub for global clinical trials.